Wellness & Workforce Solution for Lupus/Lupus Nephritis
Conditions: Lupus Nephritis Interventions: Behavioral: Micro-learning content; Behavioral: Health360x app; Behavioral: Culturally congruent coaching Sponsors: Morehouse School of Medicine; Janssen Scientific Affairs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Disease and Biomarker Profiling of Chinese Lupus Nephritis
Conditions: Characterize the Molecular Profile of Lupus Nephritis(LN) Patients to Understand Themechanism(s)Contributing to Patient Responsiveness to Soc; Integrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease Endotype; Validate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring Interventions: Other Sponsors: Nan Shen; Novartis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Anemia in Systemic Lupus Erythematosus Specially Refractory Type
Conditions: Refractory Anemia in Systemic Lupus Erythematosis Interventions: Combination Product: Laboratory investigtions Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants
Conditions: Systemic Lupus Erythematosus Interventions: Drug: GSK4347859; Drug: Placebo Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
MB-CART19.1 in Refractory SLE
Conditions: SLE - Systemic Lupus Erythematosus Interventions: Biological: MB-CART19.1 Sponsors: Miltenyi Biomedicine GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
Conditions: SLE Interventions: Drug: APG-2575; Other: Placebo Sponsors: Ascentage Pharma Group Inc.; Suzhou Yasheng Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
Conditions: Lupus Nephritis Sponsors: Chinese SLE Treatment And Research Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic Interventions: Behavioral: HIIT combined with resistance training Sponsors: Karolinska Institutet; Swedish Rheumatism Association; Region Örebro County; County Council of Norrbotten, Sweden; Karolinska University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus Interventions: Other: The Morisky Medication Adherence Scale Sponsors: University Hospital, Toulouse Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
Conditions: Systemic Lupus Erythematosus Interventions: Biological: MK-6194; Biological: Placebo Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Conditions: Lupus Nephritis; Chronic Kidney Diseases Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Standard maintenance therapy Sponsors: The University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
A Study of IMPT-514 in Active Refractory Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus; Lupus Nephritis Interventions: Biological: IMPT-514; Biological: IMPT-514; Biological: IMPT-514 Sponsors: ImmPACT Bio Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus Interventions: Other: lipid profile Sponsors: Assiut University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
Conditions: SLE (Systemic Lupus) Interventions: Other: CAR T-cell therapy Sponsors: Chulalongkorn University; King Chulalongkorn Memorial Hospital; Health Systems Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus (SLE) Interventions: Drug: SG301 SC Injection Sponsors: Hangzhou Sumgen Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
